Dantrolene prodrugs and methods of their use
US12269815B2 · kind B2 · utility
0Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2022 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Jul 22, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65586
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure is directed to dantrolene prodrugs, compositions thereof, and methods of their use in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.